Aligos Therapeutics Inc. (NASDAQ: ALGS)
$0.51
-0.0145 ( -2.79% ) 167.0K
Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
Market Data
Open
$0.51
Previous close
$0.52
Volume
167.0K
Market cap
$39.83M
Day range
$0.48 - $0.53
52 week range
$0.35 - $1.20
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| ars | Annual reports | 1 | Apr 29, 2024 |
| def | Proxies and info statements | 3 | Apr 29, 2024 |
| pre | Proxies and info statements | 3 | Apr 16, 2024 |
| 10-k | Annual reports | 104 | Mar 12, 2024 |
| 8-k | 8K-related | 16 | Mar 12, 2024 |
| 4 | Insider transactions | 1 | Mar 04, 2024 |
| 4 | Insider transactions | 1 | Mar 04, 2024 |
| 4 | Insider transactions | 1 | Mar 04, 2024 |
| 4 | Insider transactions | 1 | Mar 04, 2024 |
| 4 | Insider transactions | 1 | Feb 28, 2024 |